AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22980168 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A to E)
Number of subjects: 167
Study 20180916 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (upgraded from RVAP)
Number of subjects: 39
Study 20180916 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT) as initial therapy
Number of subjects: 39
Study 18568272 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 622
Study 15759527 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional exercise at the weekend provided by nursing staff
Number of subjects: 41
Study 15759527 — intervention group
Group type: COMPARATOR
Intervention: Usual care during weekdays and weekend
Number of subjects: 41
Study 12442560 — intervention group
Group type: EXPERIMENTAL
Intervention: Anonymous assessment
Number of subjects: 358
Study 12442560 — intervention group
Group type: COMPARATOR
Intervention: Confidential assessment
Number of subjects: 358
Study 12442560 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 358
Study 12442560 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 358
Study 12442560 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher erotophilia
Number of subjects: 358
Study 10356736 — intervention group
Group type: EXPERIMENTAL
Intervention: Act-Hib vaccine
Number of subjects: 0
Study 7497560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg with sodium citrate/bicarbonate
Number of subjects: 45
Study 7497560 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg
Number of subjects: 45
Study 7497560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 1770397 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminosyn‐PF
Number of subjects: 44
Study 1770397 — intervention group
Group type: EXPERIMENTAL
Intervention: Troph‐Amine
Number of subjects: 44
Study 6812106 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg methylphenidate
Number of subjects: 25
Study 6812106 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.50 mg/kg methylphenidate
Number of subjects: 25
Study 6812106 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg methylphenidate
Number of subjects: 25
Study 6812106 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 31870925 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 0
Study 30914065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 30914065 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Exercise Therapy (GET)
Number of subjects: 0
Study 30914065 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28763702 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable vibrotactile biofeedback system (turned on)
Number of subjects: 10
Study 28763702 — intervention group
Group type: COMPARATOR
Intervention: Control condition (biofeedback system turned off)
Number of subjects: 10
Study 26166519 — intervention group
Group type: EXPERIMENTAL
Intervention: e.max press all-ceramic onlays
Number of subjects: 45
Study 26166519 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal crowns
Number of subjects: 45
Study 26166519 — intervention group
Group type: COMPARATOR
Intervention: Resin (control)
Number of subjects: 45
Study 22520720 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive volume deflation (10% of total volume every hour for 5 hours; group V)
Number of subjects: 30
Study 22520720 — intervention group
Group type: COMPARATOR
Intervention: Ratio weaning (4 consecutive hours of a 1:2 assisting ratio followed by 1 hour of a 1:3 ratio; group R)
Number of subjects: 30
Study 22005425 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutered group (neutered at 19 weeks old)
Number of subjects: 24
Study 22005425 — intervention group
Group type: COMPARATOR
Intervention: Entire group (kept entire)
Number of subjects: 24
Study 18692788 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support with vaginal progesterone gel (Crinone 8% gel)
Number of subjects: 214
Study 18692788 — intervention group
Group type: COMPARATOR
Intervention: No luteal phase support
Number of subjects: 214
Study 17529865 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.25%)
Number of subjects: 133
Study 17529865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 15595257 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel coated EVD catheters (Bioglide, Medtronic)
Number of subjects: 158
Study 15595257 — intervention group
Group type: COMPARATOR
Intervention: Standard silastic EVD catheters
Number of subjects: 158
Study 11791803 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent depressive episodes
Number of subjects: 750
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiation (IF) to 55.8 Gy
Number of subjects: 178
Study 9747829 — intervention group
Group type: COMPARATOR
Intervention: Standard whole bone radiation (SF) to 55.8 Gy
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (C/A) followed by radiotherapy
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical patients +/− postoperative radiotherapy
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized patients undergoing radiotherapy
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of radiotherapy
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Site of primary tumor
Number of subjects: 178
Study 9747829 — intervention group
Group type: EXPERIMENTAL
Intervention: Patterns of failure
Number of subjects: 178
Study 7843870 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontraditional distant prayer
Number of subjects: 21
Study 7843870 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 21
Study 2896685 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable humidifying systems ('Conchapak')
Number of subjects: 116
Study 2896685 — intervention group
Group type: COMPARATOR
Intervention: Reusable humidifying systems
Number of subjects: 116
Study 30591616 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting (NHV) program (right@home) with 25 nurse visits until child age 2 years
Number of subjects: 722
Study 30591616 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting (NHV) program (right@home)
Number of subjects: 722
Study 28219063 — intervention group
Group type: EXPERIMENTAL
Intervention: CSU patients
Number of subjects: 32
Study 28219063 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 25245190 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir (300 mg/100 mg) with 0.35 mg norethindrone
Number of subjects: 10
Study 25245190 — intervention group
Group type: COMPARATOR
Intervention: Other antiretroviral therapy known to not alter norethindrone levels
Number of subjects: 10
Study 24126713 — intervention group
Group type: EXPERIMENTAL
Intervention: nebivolol/HCTZ
Number of subjects: 22
Study 24126713 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol/HCTZ
Number of subjects: 22
Study 22336361 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 226
Study 22336361 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A plus iron
Number of subjects: 226
Study 22336361 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient-fortified seasoning powder (7 + 1)
Number of subjects: 226
Study 19508744 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 20
Study 16850457 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO group (n = 22)
Number of subjects: 47
Study 16850457 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 47
Study 16146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide infused during PCI
Number of subjects: 0
Study 11703958 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus statins (simvastatin and pravastatin)
Number of subjects: 70
Study 11703958 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 70
Study 9394096 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone cypionate (TC) 100 mg/wk
Number of subjects: 0
Study 9394096 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone cypionate (TC) 250 mg/wk
Number of subjects: 0
Study 9394096 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone cypionate (TC) 500 mg/wk
Number of subjects: 0
Study 9394096 — intervention group
Group type: COMPARATOR
Intervention: Testosterone cypionate (TC) placebo
Number of subjects: 0
Study 7971536 — intervention group
Group type: COMPARATOR
Intervention: Content only
Number of subjects: 614
Study 7971536 — intervention group
Group type: COMPARATOR
Intervention: Content plus supervised practice on a model
Number of subjects: 614
Study 7971536 — intervention group
Group type: COMPARATOR
Intervention: Content plus individual instruction on their own breasts
Number of subjects: 614
Study 3371838 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinaverium bromide (4 mg)
Number of subjects: 10
Study 3371838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31744959 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vascular endothelial growth factor (VEGF) assessment
Number of subjects: 250
Study 31744959 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical biomarker (CB) module
Number of subjects: 250
Study 31744959 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical module tested on all 250 patients
Number of subjects: 250
Study 31744959 — intervention group
Group type: COMPARATOR
Intervention: Comparison with healthy controls
Number of subjects: 250
Study 28270277 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (n=14) with CARE kV (100 kV, 214 mA) and sinogram‐affirmed iterative reconstruction
Number of subjects: 27
Study 28270277 — intervention group
Group type: COMPARATOR
Intervention: Group B (n=13) with CARE kV (100 kV, 171 mA) and advanced modeled iterative reconstruction
Number of subjects: 27
Study 28270277 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study 26900641 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 2155
Study 26900641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2155
Study 24763155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 30
Study 24763155 — intervention group
Group type: COMPARATOR
Intervention: Yoga
Number of subjects: 30
Study 22382604 — intervention group
Group type: EXPERIMENTAL
Intervention: Early MRI within 2 weeks
Number of subjects: 46
Study 22382604 — intervention group
Group type: COMPARATOR
Intervention: Conventional management with physiotherapy
Number of subjects: 46
Study 19171641 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-deprived electroencephalogram
Number of subjects: 206
Study 19171641 — intervention group
Group type: COMPARATOR
Intervention: Routine electroencephalogram
Number of subjects: 206
Study 17506222 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors
Number of subjects: 0
Study 17506222 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 14766687 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear ocular hydro-gel (Vidisic)
Number of subjects: 92
Study 14766687 — intervention group
Group type: COMPARATOR
Intervention: Ocular dexpanthenol ointment (Oleovit)
Number of subjects: 92
Study 12390061 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (reviparin sodium, 4200 anti-Xa IU)
Number of subjects: 1279
Study 12390061 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulant (acenocoumarol, INR 2-3)
Number of subjects: 1279
Study 9922426 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphacap cement
Number of subjects: 10
Study 9922426 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji Cap I cement
Number of subjects: 10
Study 9922426 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia 21 cement
Number of subjects: 10
Study 9922426 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse diamonds
Number of subjects: 10
Study 9922426 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine diamonds
Number of subjects: 10
Study 7547378 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide therapy
Number of subjects: 122
Study 7547378 — intervention group
Group type: COMPARATOR
Intervention: Control therapies
Number of subjects: 122
Study 2232659 — intervention group
Group type: EXPERIMENTAL
Intervention: anapriline
Number of subjects: 60
Study 2232659 — intervention group
Group type: EXPERIMENTAL
Intervention: corinfar
Number of subjects: 60
Study 2232659 — intervention group
Group type: EXPERIMENTAL
Intervention: reserpine
Number of subjects: 60
Study 387619 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 50
Study 387619 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 50
Study 31956924 — intervention group
Group type: COMPARATOR
Intervention: 4 kg/head/day concentrate
Number of subjects: 40
Study 31956924 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 kg/head/day concentrate
Number of subjects: 40
Study 31956924 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 kg/head/day concentrate
Number of subjects: 40
Study 31956924 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 kg/head/day concentrate
Number of subjects: 40
Study 31120950 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversification of portfolios during the crisis
Number of subjects: 0
Study 31120950 — intervention group
Group type: EXPERIMENTAL
Intervention: Similarity of investments of different funds
Number of subjects: 0
Study 31120950 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlap of investments
Number of subjects: 0
Study 31120950 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic risk component from portfolio similarity
Number of subjects: 0
Study 28322128 — intervention group
Group type: EXPERIMENTAL
Intervention: HHQ-reduced coffee
Number of subjects: 0
Study 28322128 — intervention group
Group type: COMPARATOR
Intervention: HHQ-containing coffee
Number of subjects: 0
Study 25867124 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol ER
Number of subjects: 946
Study 25867124 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone CR
Number of subjects: 946
Study 25867124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 946
Study 25098611 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNB using a core biopsy needle
Number of subjects: 116
Study 25098611 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA using a standard aspiration needle
Number of subjects: 116
Study 21842158 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose (0.5 g/l)
Number of subjects: 0
Study 21842158 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (1 g/l)
Number of subjects: 0
Study 21842158 — intervention group
Group type: COMPARATOR
Intervention: Placebo dose (0 g/l)
Number of subjects: 0
Study 19637645 — intervention group
Group type: EXPERIMENTAL
Intervention: New softening agent formulations (non-ionic surfactants or non-toxic ingredients)
Number of subjects: 0
Study 19637645 — intervention group
Group type: COMPARATOR
Intervention: Commercially available phenol-based formulation
Number of subjects: 0
Study 19637645 — intervention group
Group type: EXPERIMENTAL
Intervention: New softening agent formulations
Number of subjects: 0
Study 17875971 — intervention group
Group type: EXPERIMENTAL
Intervention: MECC
Number of subjects: 150
Study 17875971 — intervention group
Group type: COMPARATOR
Intervention: OPCABG
Number of subjects: 150
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 12
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 12
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (0.25 microg/kg body weight) + Atropine
Number of subjects: 12
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (1 microg/kg body weight) + Atropine
Number of subjects: 12
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (0.25 microg/kg body weight) + Pyridostigmine
Number of subjects: 12
Study 15356087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (1 microg/kg body weight) + Pyridostigmine
Number of subjects: 12
Study 11255933 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pharmacological and behavioral treatments
Number of subjects: 0
Study 11255933 — intervention group
Group type: COMPARATOR
Intervention: Self-help materials only
Number of subjects: 0
Study 9738781 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene ointment on weekdays and halobetasol ointment on weekends
Number of subjects: 44
Study 9738781 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment on weekdays and halobetasol ointment on weekends
Number of subjects: 44
Study 7993168 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue identification bracelet
Number of subjects: 134
Study 7993168 — intervention group
Group type: COMPARATOR
Intervention: No bracelet (Control)
Number of subjects: 134
Study 2223935 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exposure to to-be-CSs
Number of subjects: 64
Study 2223935 — intervention group
Group type: COMPARATOR
Intervention: Fear-relevant stimuli
Number of subjects: 64
Study 2223935 — intervention group
Group type: EXPERIMENTAL
Intervention: Short rest period before acquisition
Number of subjects: 64
Study 2223935 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended rest period before acquisition
Number of subjects: 64
Study 2223935 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential conditioning
Number of subjects: 64
Study 320478 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 10 mg with morphine
Number of subjects: 450
Study 320478 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine 5 mg with morphine
Number of subjects: 450
Study 320478 — intervention group
Group type: COMPARATOR
Intervention: Morphine alone (3, 6 or 12 mg)
Number of subjects: 450
Study 31388790 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dissection (BD)
Number of subjects: 40
Study 31388790 — intervention group
Group type: COMPARATOR
Intervention: Telescopic dissection (TD)
Number of subjects: 40
Study 28140641 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy
Number of subjects: 32
Study 28140641 — intervention group
Group type: COMPARATOR
Intervention: Physical rehabilitation with sham photobiomodulation treatment
Number of subjects: 32
Study 28140641 — intervention group
Group type: COMPARATOR
Intervention: Sham photobiomodulation treatment only
Number of subjects: 32
Study 26166378 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone (5 mg)
Number of subjects: 150
Study 26166378 — intervention group
Group type: COMPARATOR
Intervention: Oral naproxen (250 mg)
Number of subjects: 150
Study 23403073 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing and positive affect and self-affirmation strategies
Number of subjects: 220
Study 21727006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate 6 mg infused over 15 min
Number of subjects: 334
Study 21727006 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate 6 mg infused over 60 min
Number of subjects: 334
Study 21727006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate 6 mg infused over 15 min and 60 min
Number of subjects: 334
Study 19803123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1%
Number of subjects: 150
Study 19803123 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 150
Study 18681089 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1%
Number of subjects: 20
Study 18681089 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 20
Study 18681089 — intervention group
Group type: COMPARATOR
Intervention: Azelastine 0.1%
Number of subjects: 20
Study 15466605 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit ethnocentrism
Number of subjects: 0
Study 15466605 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit ethnocentrism
Number of subjects: 0
Study 15466605 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit and explicit attitudes
Number of subjects: 0
Study 15466605 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent variable modeling
Number of subjects: 0
Study 11506105 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (intradermal needles inserted at acupoints 2.5 cm from the spinal vertebrae)
Number of subjects: 175
Study 11506105 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 175
Study 10065907 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam (30 mg)
Number of subjects: 60
Study 10065907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7976143 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 micrograms.kg‐1
Number of subjects: 120
Study 7976143 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms.kg‐1
Number of subjects: 120
Study 7976143 — intervention group
Group type: COMPARATOR
Intervention: Control (Propofol alone)
Number of subjects: 120
Study 2522899 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of ovulation with pFSH/hCG
Number of subjects: 18
Study 2522899 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of ovulation with pFSH/hMG/hCG
Number of subjects: 18
Study 2522899 — intervention group
Group type: EXPERIMENTAL
Intervention: Down-regulation of the ovaries with a GnRH analogue (Decapeptyl)
Number of subjects: 18
Study 4135024 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulated at the peak of alpha wave with clicks
Number of subjects: 0
Study 4135024 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulated midway on the up going portion of the wave with flashes
Number of subjects: 0
Study 4135024 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulated at the trough of the wave in the paired condition
Number of subjects: 0